SB02024 was found to suppress autophagy and tumor growth in CRC, melanoma [105], and breast cancer [13] and to improve the therapeutic benefit of anti-PD-L1/PD-1 immunotherapy [105], sunitinib, and erlotinib [13]. Here, CD274 is linked to breast cancer.